Ignite Creation Date:
2024-05-06 @ 3:29 PM
Last Modification Date:
2024-10-26 @ 1:50 PM
Study NCT ID:
NCT04641442
Status:
RECRUITING
Last Update Posted:
2024-06-25
First Post:
2020-11-20
Brief Title:
Study to Evaluate the Efficacy Safety and Tolerability of MAS825 in Patients With Monogenic IL-18 Driven Autoinflammatory Diseases Including NLRC4-GOF XIAP Deficiency or CDC42 Mutations
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-12-18
Start Date Type:
ACTUAL
Primary Completion Date:
2025-07-11
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-09-30
Completion Date Type:
ESTIMATED
First Submit Date:
2020-11-20
First Submit QC Date:
November 20 2020
Study First Post Date:
2020-11-23
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-09-18
Last Update Post Date:
2024-06-25
Last Update Post Date Type:
ACTUAL